News from the ECE Department
Subscribe to the ECE News and Calendar RSS Feed
Solzbacher awarded Tech Comm Project for medical drug delivery system
Device-based Local Delivery of a Mast Cell-specific Tyrosine Kinase Inhibitor to Mitigate the Implant Foreign Body Response
The TCP Scientific Advisory Committee of the University of Utah Research Foundation recently awarded Prof. Florian Solzbacher $35,000 for his project, "Device-based Local Delivery of a Mast Cell-specific Tyrosine Kinase Inhibitor to Mitigate the Implant Foreign Body Response."
Technology Commercialization Projects
The Technology Commercialization Project (TCP) program, formerly known as the Technology Innovation Grant (TIG) program is funded by the University of Utah Research Foundation to further develop novel technologies that are near-commercialization.This program will support research/development in all areas of technology including medical devices, biomaterials, drug design and development, immunodiagnostics, electronics, software, communications, engineering, etc.The goal for each funded TCP is to have the technology ready for licensing to a company for commercialization by the end of the two year funding period.